双层溶解微针,用于用微乳液介导的布里莫尼丁酸盐在玻璃眼癌治疗中的眼部输送
Nisha Rajbhar1, Harsh P Nijhawan1, Khushwant S Yadav1
1Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS (Deemed to be University), Mumbai, India.
Journal of biomaterials science. Polymer edition
|March 11, 2026
概括
一种新型的微针系统可以有效地提供布里莫尼丁酸盐 (BRT),降低青光眼患者的眼内压力 (IOP). 这种先进的药物输送改善了保留和疗效,提供了更好的治疗选择.
科学领域:
- 眼科医生 眼科 眼科
- 材料科学 材料科学 材料科学
- 药品制造 药品制造 药品制造
背景情况:
- 玻璃眼瘤是全球不可逆转失明的主要原因,通常与眼内压力 (IOP) 升高有关.
- 目前的布里莫尼丁酸 (BRT) 眼滴具有局限性,包括快速清除和较差的角膜透,导致合规问题.
- 需要持续的眼部药物输送系统来改善绿眼管理的治疗结果.
研究的目的:
- 开发和评估基于微乳液 (ME) 的双层溶解微针 (BDMNs) 系统,用于持续向眼部输送布里莫尼丁酸盐 (BRT).
- 优化BRT-ME配方,并评估BDMNs系统的性能,以改善绿眼治疗.
主要方法:
- 使用D-最佳设计优化BRT-ME配方,以滴滴大小,粘度,清晰度和稳定性为特征.
- 集成优化ME到一个双层微针矩阵 (PVA,奇托桑,Poloxamer 407) 具有高机械完整性.
- 在子模型中评估了BRT释放动力学,ex vivo角膜透,眼部刺激和体内IOP降低.
主要成果:
- 优化的BRT-ME表现出有利的物理化学特性和热力学稳定性.
- 该BDMN系统表现出强大的机械完整性和高插入效率.
- 观察到持续的BRT释放 (>95%在24小时内) 和增强的角膜透.
- 在体内研究表明,显著的IOP降低 (~47%) 优于单独的BRT-ME,具有很好的生物相容性.
结论:
- BRT-ME-BDMNs系统为持续的眼部药物输送提供了一个稳定,最小侵入性的平台.
- 这种新的系统显著提高了药物保留率和治疗疗效,用于治疗青光眼.
- BRT-ME-BDMNs代表了一种有前途的下一代方法,用于有效的青光眼治疗.
相关概念视频
Ophthalmic Drug Delivery Systems
154
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
154
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Drug Delivery: Miscellaneous Routes
925
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
925
Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K


